Raymond W. Cohen Joins Nalu Medical’s Board as Chairman

Nalu Medical Inc. has appointment life sciences executive Raymond W. Cohen as chairman of its Board of Directors.

Cohen is an accredited public company director with more than 40 years of experience in the life sciences industry. He received the 2024 MedTech MVP Award and was also named Businessperson of the Year in 2024 by the Orange County Business Journal. Cohen received a lifetime achievement award from SoCalBio in 2021 for his four decades of work in medical technology and In late 2020, was named Entrepreneur of the Year by Ernst & Young for the Pacific Southwest.

Cohen was CEO and board member of Nasdaq-listed Axonics Inc., a medical device company he co-founded in 2013 and took public in late October 2018. Axonics topped the 2021 and 2022 Deloitte Technology Fast 500 and Financial Times ranking of the fastest growing companies in the Americas. Cohen retired from Axonics after closing its $3.7 billion sale to Boston Scientific Corporation last fall.

Following Axonics’ sale, Cohen became board chairman at SoniVie Ltd., a privately held, Israel-based developer of a renal denervation system for hypertension treatment. Cohen was instrumental in the $600 million sale to Boston Scientific in March. In addition, Cohen serves on the board of directors of Kestra Medical Technologies, a commercial stage company manufacturing and marketing a wearable defibrillator product for patients at temporary risk of cardiac arrest. Kestra completed an oversubscribed IPO in early March, raising $232 million in gross proceeds.

“We look forward to benefiting from Mr. Cohen’s broad experience in growing medtech companies and his expertise in neuromodulation as we seek to significantly increase adoption of our peripheral nerve stimulation system,” Nalu Medical President/CEO Tom West said.

The Nalu System consists of a fully featured, miniaturized implantable pulse generator (IPG) that is powered wirelessly by an externally worn Therapy Disc and controlled through a smartphone-based remote-control app. Despite its small size, the Nalu micro-IPG delivers treatment capabilities similar to larger IPGs and features unique advantages associated with advanced waveforms, extensive programming options, exceptional upgradability, and an 18-year expected service life. The Nalu System has been named one of the world’s top 100 new products by R&D Magazine in 2021. It is cleared by the U.S. Food and Drug Administration for peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) indications.

Nalu Medical is a Carlsbad, Calif.-based medical technology company developing and commercializing minimally invasive solutions for patients with chronic neuropathic pain. The Nalu Neurostimulation System delivers gentle electrical pulses to the nervous system to modulate pain signals before they reach the brain. The Nalu System was designed to address major unmet needs in treating chronic neuropathic pain and provide a differentiated value proposition for patients and physicians.